BRCA1 & BRCA2 Deletion/Duplication Analysis is a genetic test that detects large deletions and duplications (copy number variations) in the BRCA1 and BRCA2 genes. These genetic changes are associated with a significantly increased risk of hereditary breast, ovarian, prostate, and pancreatic cancers.
Reporting Time: 2–4 weeks (may vary by laboratory)
Who Should Consider This Test?
Individuals with a strong family history of breast or ovarian cancer
Patients diagnosed with breast cancer at a young age
Individuals with bilateral or multiple primary cancers
Families with known BRCA mutations
Men with breast cancer or a family history of hereditary cancers
Those seeking hereditary cancer risk assessment
Why is This Test Important?
Detects large gene deletions and duplications missed by routine sequencing
Identifies inherited cancer susceptibility
Helps estimate lifetime cancer risk
Supports personalized cancer screening and prevention
Assists in treatment decisions, including targeted therapies
Enables genetic counseling and family risk assessment
Conditions Associated
Hereditary Breast Cancer
Ovarian Cancer
Prostate Cancer
Pancreatic Cancer
Hereditary Breast and Ovarian Cancer (HBOC) Syndrome
Benefits
Early identification of hereditary cancer risk
Personalized surveillance strategies
Informed preventive healthcare decisions
Better treatment planning
Family members can undergo predictive testing if required
Preparation
No special preparation or fasting is required. Genetic counseling before and after testing is recommended for proper interpretation of results.
Book Your Test Today
Take a proactive step toward protecting your health with BRCA1 & BRCA2 Deletion/Duplication Analysis. Early genetic risk detection empowers timely screening, preventive care, and informed healthcare decisions.